Livmarli Uniunea Europeană - română - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

LIVMARLI 9,5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

livmarli 9,5 mg/ml

millmount healthcare limited - irlanda - maralixibatum - sol. orala - 9,5mg/ml - terapia vezicii biliare alte medicamente pentru terapia vezicii